Prognostic Significance of Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Liver Transplantation for Hepatocellular Carcinoma
Current Oncology · 2025
DOI: 10.3390/curroncol32080464 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Current Oncology, 2025. Verfasst von Imam Bakir Bati und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Transplant Surgery, Faculty of Medicine, Acıbadem University, Istanbul 34752, Turkey. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Transplantation, Hemoglobins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Hepatocellular carcinoma (HCC) remains a major indication for liver transplantation (LT), but accurate pretransplant risk stratification is critical to improve long-term outcomes. Traditional morphometric criteria such as tumor size and number are limited in predicting recurrence and survival. The HALP (hemoglobin, albumin, lymphocyte, platelet), gamma-glutamyl transpeptidase to platelet ratio (GPR), and FIB-4 indices are emerging systemic inflammatory and nutritional biomarkers that may provide additional prognostic value in HCC patients undergoing LT. Materials and Methods: This retrospective, two-center cohort study included 200 patients who underwent LT for HCC between 2012 and 2023. Preoperative HALP, GPR, and FIB-4 scores were calculated, and their associations with overall survival (OS) and recurrence-free survival (RFS) were assessed using ROC analyses and Cox proportional hazard models. Cut-off values were determined for each biomarker, and survival outcomes were analyzed using Kaplan–Meier methods.
Results
A low HALP score (≤0.39) was independently associated with reduced OS but not with RFS. Conversely, low GPR (≤0.45) and FIB-4 (≤3.1) values were significantly associated with both poor OS and higher recurrence risk. Tumor size, number of lesions, and microvascular invasion also independently predicted poor outcomes. Multivariate analysis confirmed HALP, GPR, and FIB-4 as significant preoperative predictors of prognosis in this population.
Conclusions
HALP, GPR, and FIB-4 are readily available, cost-effective indices that provide significant prognostic information in HCC patients undergoing LT. Their integration with morphometric criteria may improve pretransplant risk stratification and support individualized clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Liver Transplant Surgery, Faculty of Medicine, Acıbadem University, Istanbul 34752, Turkey.
- Department of Liver Transplant Surgery, Şişli Etfal Hamidiye Training and Research Hospital, Istanbul 34360, Turkey.
- Department of Anesthesiology and Reanimation, Gaziantep City Hospital, Gaziantep 27100, Turkey.
ORCID-Profile: Elif Eygi
Zitieren
APA
Bati, I. B., Tuysuz, U., & Eygi, E. (2025). Prognostic Significance of Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Liver Transplantation for Hepatocellular Carcinoma. Current Oncology. https://doi.org/10.3390/curroncol32080464
Vancouver
Bati IB, Tuysuz U, Eygi E. Prognostic Significance of Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Liver Transplantation for Hepatocellular Carcinoma. Current Oncology. 2025. doi:10.3390/curroncol32080464
BibTeX
@article{Bati2025,
author = {Bati, Imam Bakir and Tuysuz, Umut and Eygi, Elif},
title = {Prognostic Significance of Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Liver Transplantation for Hepatocellular Carcinoma},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32080464}
}
EUVIMED